Scientists at the University of Surrey have discovered that a natural antioxidant commonly found in green tea can help eliminate antibiotic resistant bacteria.
The study, published in the Journal of Medical Microbiology, found that epigallocatechin (EGCG) can restore the activity of aztreonam, an antibiotic commonly used to treat infections caused by the bacterial pathogen Pseudomonas aeruginosa.
P. aeruginosa is associated with serious respiratory tract and bloodstream infections and in recent years has become resistant to many major classes of antibiotics. Currently a combination of antibiotics is used to fight P. aeruginosa. However, these infections are becoming increasingly difficult to treat, as resistance to last line antibiotics is being observed.
To assess the synergy of EGCG and aztreonam, researchers conducted in vitro tests to analyse how they interacted with the P. aeruginosa, individually and in combination. The Surrey team found that the combination of aztreonam and EGCG was significantly more effective at reducing P. aeruginosa numbers than either agent alone.
This synergistic activity was also confirmed in vivo using Galleria mellonella (Greater Wax Moth larvae), with survival rates being significantly higher in those treated with the combination than those treated with EGCG or aztreonam alone. Furthermore, minimal to no toxicity was observed in human skin cells and in Galleria mellonella larvae.
Researchers believe that in P. aeruginosa, EGCG may facilitate increased uptake of aztreonam by increasing permeability in the bacteria. Another potential mechanism is EGCG’s interference with a biochemical pathway linked to antibiotic susceptibility.
Lead author Dr Jonathan Betts, Senior Research Fellow in the School of Veterinary Medicine at the University of Surrey, said: “Antimicrobial resistance (AMR) is a serious threat to global public health. Without effective antibiotics, the success of medical treatments will be compromised. We urgently need to develop novel antibiotics in the fight against AMR. Natural products such as EGCG, used in combination with currently licenced antibiotics, may be a way of improving their effectiveness and clinically useful lifespan.”
Professor Roberto La Ragione, Head of the Department of Pathology and Infectious Diseases in the School of Veterinary Medicine at the University of Surrey, said: “The World Health Organisation has listed antibiotic resistant Pseudomonas aeruginosa as a critical threat to human health. We have shown that we can successfully eliminate such threats with the use of natural products, in combination with antibiotics already in use. Further development of these alternatives to antibiotics may allow them to be used in clinical settings in the future.”
The Latest on: Antibiotic resistant bacteria
via Google News
The Latest on: Antibiotic resistant bacteria
- Gel fights drug-resistant bacteria and induces body's natural immune defenseon October 14, 2021 at 7:52 am
In the fight against multidrug-resistant bacteria, scientists in Sweden have developed a new kind of antibiotic-free protection for wounds that kills drug-resistant bacteria and induces the body's own ...
- Antibiotic-Resistant Biofilm Survives Silver Bulleton October 13, 2021 at 5:00 am
New research from scientists at the University of Technology Sydney (UTS) demonstrates long-term nanosilver treatment can increase the risk of recurrent infections of antibiotic-resistant pathogenic ...
- Scientists move a step closer to harnessing viruses to fight antibiotic resistanceon October 12, 2021 at 6:30 pm
As antibiotics increasingly develop resistance to bacteria that cause infection, scientists have moved a step closer to harnessing viruses as an alternative form of therapy.
- Phage therapy research brings scientists a step closer to harnessing viruses to fight antibiotic resistanceon October 12, 2021 at 11:00 am
As bacteria that cause infection increasingly develop resistance to antibiotics, scientists have moved a step closer to harnessing viruses as an alternative form of therapy.
- MIT Researchers Make Progress on Antibiotic Resistance Under DTRA-JSTO Research Programon October 12, 2021 at 8:23 am
Researchers are making significant progress in antibiotic resistance under the Discovery of Medical Countermeasures Against New and Emerging threats ...
- Antibiotic Resistance Market Sales Revenue to Significantly Increase in the Next Few Yearson October 11, 2021 at 11:47 pm
The Antibiotic Resistance Market is expected to be worth US 12 6 Bn at a CAGR of 4 between 2021 to 2031 Healthcare is going the digital way In other words artificial intelligence AI enabled medical ...
- "Living medicine" recruits bacteria to fight antibiotic-resistant superbugson October 7, 2021 at 6:31 pm
Scientists have demonstrated a new way to fight antibiotic-resistant superbugs by pitting bacteria against each other. The team engineered a common bacteria to safely colonize the surface of medical ...
- First ‘living medicine’ that treats antibiotic-resistant bacteria developed by scientistson October 7, 2021 at 3:25 am
Researchers in Spain have created the world’s first “living medicine” to treat antibiotic-resistant bacteria growing on the surfaces of medical implants. The team at Barcelona’s Centre for Genomic ...
- Antibiotic-Resistant Biofilms Eliminated by “Living Medicine”on October 6, 2021 at 2:45 pm
Antibiotic-resistant biofilms eradicated by bacteria engineered to be nonpathogenic and to release biofilm-busting and bactericidal factors ...
- Experts create ‘living medicine’ to treat antibiotic-resistant bacteriaon October 6, 2021 at 3:03 am
Bacteria on medical implants can be highly resistant to antibiotics and account for a large proportion of hospital-acquired infections.
via Bing News